The Drug Enforcement Administration (DEA) published a document in the Federal Register on May 6, 2024, concerning an application for a Bulk Manufacturer of Controlled Substances. A request was made for the removal of the following information: "The company plans to bulk manufacture the listed controlled substances for the purpose of producing material for clinical trials." Please correct notice to read as follows as stated under Supplementary Information.